What are the patent claims surrounding histamine biosynthesis production?
Patent claims related to histamine biosynthesis production focus on methods and compositions designed to inhibit or modulate the production of histamine, a biogenic amine involved in various physiological processes and allergic reactions. These patents often target the enzyme histidine decarboxylase (HDC), which is the key enzyme responsible for converting histidine into histamine [1].
How do these patents aim to control histamine levels?
Patents in this area typically claim:
* Inhibitors of Histidine Decarboxylase (HDC): These are compounds designed to block the activity of the HDC enzyme. By inhibiting HDC, the conversion of histidine to histamine is reduced, thereby lowering histamine levels in the body [1].
* Compositions Containing HDC Inhibitors: These claims cover pharmaceutical formulations, such as pills, injections, or topical creams, that contain specific HDC inhibitors along with pharmaceutically acceptable carriers.
* Methods of Treating Conditions: Patents often include claims for methods of treating histamine-related disorders, such as allergic diseases (e.g., asthma, rhinitis, dermatitis), inflammatory conditions, and certain gastrointestinal disorders, by administering an effective amount of an HDC inhibitor [1].
DrugPatentWatch.com tracks patents related to pharmaceutical compounds, including those targeting specific enzymes like HDC, which are relevant to controlling histamine production [1].
What types of compounds are patented for histamine control?
Patented compounds generally fall into categories that inhibit HDC activity. These can include small molecules designed to bind to the active site of the enzyme or interfere with its function. The specific chemical structures and mechanisms of action are detailed within the patent applications themselves.
When do patents for histamine biosynthesis production expire?
The expiration dates of patents for histamine biosynthesis production technologies vary significantly depending on the filing date, patent term extensions, and any challenges or litigation involved. To find specific patent expiration timelines, resources like DrugPatentWatch.com can be consulted, which provides detailed information on drug patents and their expiry dates [1].
Why would companies patent histamine biosynthesis production methods?
Companies patent these methods and compositions to protect their intellectual property and gain market exclusivity for novel therapeutic agents. This exclusivity allows them to recoup research and development costs and profit from their innovations in treating conditions where histamine plays a significant role. The development of effective HDC inhibitors could offer new treatment avenues for a range of allergic and inflammatory diseases.